Cite
Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
MLA
Bo Xiao, et al. “Identification and Validation of Immune‐related LncRNA Prognostic Signatures for Melanoma.” Immunity, Inflammation and Disease, vol. 9, no. 3, Sept. 2021, pp. 1044–54. EBSCOhost, https://doi.org/10.1002/iid3.468.
APA
Bo Xiao, Liyan Liu, Aoyu Li, Pingxiao Wang, Cheng Xiang, Hui Li, & Tao Xiao. (2021). Identification and validation of immune‐related lncRNA prognostic signatures for melanoma. Immunity, Inflammation and Disease, 9(3), 1044–1054. https://doi.org/10.1002/iid3.468
Chicago
Bo Xiao, Liyan Liu, Aoyu Li, Pingxiao Wang, Cheng Xiang, Hui Li, and Tao Xiao. 2021. “Identification and Validation of Immune‐related LncRNA Prognostic Signatures for Melanoma.” Immunity, Inflammation and Disease 9 (3): 1044–54. doi:10.1002/iid3.468.